CLASS III Drug recall · Reported 1 Nov 2017 · FDA Enforcement Report
AndroGel (testosterone gel) 62%, 88 gm metered-dose pump recalled
AbbVie is recalling AndroGel (testosterone gel) 62%, 88 gm metered-dose pump, 25 mg of testosterone per pump, distributed in Arizona. The recall was initiated on 8 Sep 2017 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0033-2018
- FDA event ID
- 78143
- Recalling firm
- AbbVie, North Chicago, IL
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 8 Sep 2017
- FDA classified
- 25 Oct 2017
- Reported
- 1 Nov 2017
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Temperature Abuse
- Drug class
- Hormones & Birth Control
Timeline
| 8 Sep 2017 | Recall initiated by company | |
| 25 Oct 2017 | Classified by FDA | +47 days |
| 1 Nov 2017 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Foods that need refrigeration and were stored or shipped too warm can grow harmful bacteria without any change in look or smell.
Product as listed by the FDA
AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testosterone per pump actuation, 60 metered pump actuations, Rx Only, Marketed by: AbbVie Inc., North Chicago, IL 60064 USA. NDC: 0051-8462-33
Where it was distributed
AZ
Questions about this recall
Is AndroGel (testosterone gel) 62%, 88 gm metered-dose pump, 25 mg of testosterone per pump recalled?
Yes. AbbVie recalled AndroGel (testosterone gel) 62%, 88 gm metered-dose pump, 25 mg of testosterone per pump on 8 Sep 2017. The recall is Class III and its status is Terminated. Recall number D-0033-2018.
Why was it recalled?
Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.
Which lots are affected?
Lot: 91122, EXP. 01/2020
Where was it sold?
AZ
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from AbbVie
All 20| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Pred Mild, prednisolone acetate ophthalmic suspension recalled by AbbViePred Mild | AbbVie | Labeling Errors | Nationwide |
| Drug | CLASS II | Refresh Lacri-lube, 5% Mineral Oil recalled by AbbVie | AbbVie | Labeling Errors | Nationwide |
| Drug | CLASS II | Refresh P.M., (Mineral Oil recalled by AbbVie | AbbVie | Labeling Errors | Nationwide |
| Drug | CLASS III | Synthroid, Levothyroxine Sodium Tablets, USP 125mcg 125mg) recalledSynthroid | AbbVie | Other | IL |
| Drug | CLASS III | Ultane (sevoflurane), Inhalation Anesthetic recalled by AbbVieUltane | AbbVie | Packaging Defects | MS, OH |